Evidence map›Paper›PMID 24586304›Full record

ArticlePloS one2014

The novel long noncoding RNA linc00467 promotes cell survival but is down-regulated by N-Myc.

Bernard Atmadibrata, Pei Y Liu, Nicolas Sokolowski, Lihong Zhang, Matthew Wong, Andrew E Tee, Glenn M Marshall, Tao Liu

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. LINC00467: an oncogenic long noncoding RNA.Cancer cell international · 2022
    Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. [Expression of long non-coding RNA linc00467 in childhood acute myeloid leukemia and its role in drug resistance].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2020
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Bernard AtmadibrataChildren's Cancer Institute Australia for Medical Research, Randwick, Sydney, Australia.
Pei Y LiuChildren's Cancer Institute Australia for Medical Research, Randwick, Sydney, Australia.
Nicolas SokolowskiChildren's Cancer Institute Australia for Medical Research, Randwick, Sydney, Australia.
Lihong ZhangChildren's Cancer Institute Australia for Medical Research, Randwick, Sydney, Australia ; Department of Anatomy, Histology and Embryology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
Matthew WongChildren's Cancer Institute Australia for Medical Research, Randwick, Sydney, Australia.
Andrew E TeeChildren's Cancer Institute Australia for Medical Research, Randwick, Sydney, Australia.
Glenn M MarshallChildren's Cancer Institute Australia for Medical Research, Randwick, Sydney, Australia ; Kids Cancer Centre, Sydney Children's Hospital, Randwick, Australia.
Tao LiuChildren's Cancer Institute Australia for Medical Research, Randwick, Sydney, Australia ; School of Women's & Children's Health, UNSW Medicine, University of New South Wales, Randwick, Sydney, Australia.
Children's Cancer Institute Australia · AUFudan University · CNUNSW Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The worst subtype of neuroblastoma is caused by MYCN oncogene amplification and N-Myc oncoprotein over-expression. Long noncoding RNAs (lncRNAs) are emerging as critical regulators of gene expression and tumourigenesis. While Myc oncoproteins are well-known to exert tumourigenic effects by regulating the expression of protein-coding genes and microRNAs, little is known about which lncRNAs are Myc targets and whether the Myc target lncRNAs play a role in Myc-induced oncogenesis. Here we performed differential gene expression studies using lncRNA microarray in neuroblastoma cells after transfection with control or N-Myc-specific small interfering RNA (siRNA), and identified N-Myc target lncRNAs including the novel lncRNA linc00467, the expression and function of which were completely unknown. RT-PCR, chromatin immunoprecipitation and luciferase assays showed that N-Myc suppressed linc00467 gene expression through direct binding to the linc00467 gene promoter and reducing linc00467 promoter activity. While N-Myc suppressed the expression of RD3, the protein-coding gene immediately down-stream of linc00467 gene, through direct binding to the RD3 gene promoter and reducing RD3 promoter activity, linc00467 reduced RD3 mRNA expression. Moreover, Affymetrix microarray analysis revealed that one of genes significantly up-regulated by linc00467 siRNA was the tumour suppressor gene DKK1. Importantly, knocking-down linc00467 expression with siRNA in neuroblastoma cells reduced the number of viable cells and increased the percentage of apoptotic cells, and co-transfection with DKK1 siRNA blocked the effects. These findings therefore demonstrate that N-Myc-mediated suppression of linc00467 gene transcription counterintuitively blocks N-Myc-mediated reduction in RD3 mRNA expression, and reduces neuroblastoma cell survival by inducing DKK1 expression.

Indexed as

Cell Line, TumorCell SurvivalDown-RegulationEye ProteinsGene Knockdown TechniquesHumansIntercellular Signaling Peptides and ProteinsPromoter Regions, GeneticProto-Oncogene Proteins c-mycRNA, Long NoncodingRNA, MessengerDKK1 protein, humanEye ProteinsIntercellular Signaling Peptides and ProteinsProto-Oncogene Proteins c-mycRD3 protein, humanRNA, Long NoncodingRNA, Messenger

Identifiers

PMID24586304
PMCPMC3929584
OpenAlexW2053948868

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.